NCT02990793 - Clinical Trial to Evaluate the Safety and Efficacy of MeRT Treatment in Post-Traumatic Stress Disorder | Biotech Hunter

Enrollment

152

Participants

Timeline

Start Date

April 4, 2022

Primary Completion Date

September 30, 2025

Study Completion Date

November 30, 2025

Conditions

PostTraumatic Stress DisorderTraumatic Brain InjuryPostconcussive Symptoms

Interventions

DEVICE

Active MeRT Treatment

A personalized biometrics-guided protocol known as magnetic EEG/ECG resonance therapy (MeRT) treatment that is tailored specifically to each participant's EEG intrinsic alpha frequency (IAF). rTMS is applied at the participant's IAF.

DEVICE

Sham MeRT Treatment

rTMS coil does not emit magnetic stimulation.

Trial Locations (8)

19010

Center for Interventional Pain and Spine, Bryn Mawr

27607

UNC Rex Hospital, Raleigh

43219

Columbus Brain Research Center, Columbus

75093

Texas A&M Research Center, Plano

90822

VA Long Beach Healthcare System, Long Beach

92103

SoCal Neuroscience Research Unit, San Diego

92626

BrainHealth Solutions, Costa Mesa

98004

Seattle Neuropsychiatric Treatment Center (Seattle NTC), Bellevue